That's a good question.
The answer is, yes, we work with Health Canada also. We are going through a process. Actually, there's the process that we go through with our five-year plan through the National Research Council, Industry Canada, and so on. There's a memorandum to cabinet that will be going forward in the next month that contains the accelerator that would be used to make these isotopes. The fact is we collaborate with MDS Nordion as our partner. It's been a 30-year manufacturing partnership with MDS Nordion.
We already produce 15% of Canada's medical isotopes. We're proposing that we produce the rest. We would do that with accelerators. We've had an international study of that published. It was funded by NRCan and it supports the approach we're taking. It's really now a decision, I think. The technology is there, and it requires much less of an infrastructure investment than in a reactor.